The Delta variant of COVID-19, first identified in India, is moving rapidly around the world.
A study conducted on 100 healthcare workers across three centers in India has found the Delta variant eight times less sensitive to antibodies generated by the COVID-19 vaccine, a local media report said Monday.
The study, named "Sars-Cov-2 B.1.617.2 Deltavariant Emergence and Vaccine Breakthrough: Collaborative Study", also found that the variant has a much higher capacity to infect more people.
The collaborative study from India was conducted along with scientists from the Cambridge Institute of Therapeutic Immunology and Infectious Disease.
"The B.1.617.2 Delta variant not only dominates vaccine-breakthrough infections with higher respiratory viral loads compared to non-delta infections but also generates greater transmission between fully vaccinated healthcare workers, as compared to other variants B.1.1.7 (Alpha variant) or B.1.617.1 (Kappa variant)," the findings of the study revealed.
The study said the Delta variant is less sensitive to neutralizing antibodies from recovered individuals, with "higher replication efficiency" as compared to the Alpha variant.
- English Study Finds Fully vaccinated People At 50 60 Lower risk of Covid Infection
- Delta Variant Rises Cause Great Stakes For Vaccination
- US crosses 50 million COVID-19 cases as Delta dominates amid Omicron emergence
- Omicron variant of the coronavirus may be milder than the delta version, studies say
- Why nearly 30 fully vaccinated people and scientist on China’s Sinovac have died with COVID-19
- More than 60 million Indians may have caught coronavirus: study
- Vietnam reports cases of Indian Covid-19 variant
- Omicron has been designated as a “variant of concern”
- Global COVID-19 deaths hit 5 million as Delta variant sweeps the world